458 related articles for article (PubMed ID: 12052032)
1. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.
Reggio PH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):143-60. PubMed ID: 12052032
[TBL] [Abstract][Full Text] [Related]
2. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids in the central nervous system--an overview.
Fride E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
5. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
6. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
[TBL] [Abstract][Full Text] [Related]
7. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
Mechoulam R
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
[TBL] [Abstract][Full Text] [Related]
8. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.
Hanus L; Abu-Lafi S; Fride E; Breuer A; Vogel Z; Shalev DE; Kustanovich I; Mechoulam R
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3662-5. PubMed ID: 11259648
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
10. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
11. Cannabinergic ligands.
Palmer SL; Thakur GA; Makriyannis A
Chem Phys Lipids; 2002 Dec; 121(1-2):3-19. PubMed ID: 12505686
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids in the immune system and cancer.
Parolaro D; Massi P; Rubino T; Monti E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
[TBL] [Abstract][Full Text] [Related]
14. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
15. Natural and synthetic endocannabinoids and their structure-activity relationships.
Palmer SL; Khanolkar AD; Makriyannis A
Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids and the gut.
Pinto L; Capasso R; Di Carlo G; Izzo AA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
[TBL] [Abstract][Full Text] [Related]
17. Presence and regulation of the endocannabinoid system in human dendritic cells.
Matias I; Pochard P; Orlando P; Salzet M; Pestel J; Di Marzo V
Eur J Biochem; 2002 Aug; 269(15):3771-8. PubMed ID: 12153574
[TBL] [Abstract][Full Text] [Related]
18. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
Di Marzo V; Griffin G; De Petrocellis L; Brandi I; Bisogno T; Williams W; Grier MC; Kulasegram S; Mahadevan A; Razdan RK; Martin BR
J Pharmacol Exp Ther; 2002 Mar; 300(3):984-91. PubMed ID: 11861807
[TBL] [Abstract][Full Text] [Related]
19. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
Giuffrida A; Beltramo M; Piomelli D
J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
